Intermediate dose of methotrexate toxicity in non-Hodgkin lymphoma - predictive value of serum methotrexate concentrations and corrective measures to avert toxicity

Author： Uluoglu C.   Oguz A.   Timlioglu O.   Biberoglu G.   Hasanoglu A.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.32, Iss.2, 1999-02, pp. : 215-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methotrexate: Non-hodgkin's lymphoma: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1092, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Methotrexate pulmonary toxicity

By Lateef Omar   Shakoor Najia   Balk Robert A  

Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. : 723-730

Informa Healthcare

Access to resources Recommend Favorite

Dose-intensified CHOP ± etoposide in non-Hodgkin's lymphoma

By  

Inpharma, Vol. 1, Iss. 1455, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Methotrexate: Drug toxicity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1351, 2011-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite

Methotrexate: Focal skin toxicity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1323, 2010-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite